Evidence map›Paper›PMID 24594863›Full record

Trial reportMenopause (New York, N.Y.)2014

Calcium/vitamin D supplementation, serum 25-hydroxyvitamin D concentrations, and cholesterol profiles in the Women's Health Initiative calcium/vitamin D randomized trial.

Peter F Schnatz, Xuezhi Jiang, Sharon Vila-Wright, Aaron K Aragaki, Matthew Nudy, David M O'Sullivan, Rebecca Jackson, Erin LeBlanc, Jennifer G Robinson, James M Shikany and 7 more

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Menopause (New York, N.Y.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 3 pooled it
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 3 syntheses or guidelines pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Serum Lipid, Vitamin D Levels, and Obesity in Perimenopausal and Postmenopausal Women in Non-Manual Employment.Medical science monitor : international medical journal of experimental and clinical research · 2017
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 10 institutions in 1 country.

Peter F SchnatzFrom the Departments of 1ObGyn and 2Internal Medicine, The Reading Hospital, Reading, PA; Departments of 3ObGyn and 4Internal Medicine, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA; 5Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA; 6Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, The Ohio State University, Columbus, OH; 7Center for Health Research NW, Kaiser Permanente, Portland, OR; 8Departments of Epidemiology and Medicine, University of Iowa, Iowa City, IA; 9Division of Preventive Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, AL; 10Department of Preventive Medicine, University of Tennessee, Memphis, TN; 11Division of Cardiology, Department of Internal Medicine, George Washington University School of Medicine and Health Sciences, Washington, DC; 12Department of Epidemiology and Prevention, Wake Forest University, Winston-Salem, NC; 13Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, MA; and 14Sticht Center on Aging, Wake Forest University, Winston-Salem, NC.
Xuezhi Jiang
Sharon Vila-Wright
Aaron K Aragaki
Matthew Nudy
David M O'Sullivan
Rebecca Jackson
Erin LeBlanc
Jennifer G Robinson
James M Shikany
Catherine R Womack
Lisa W Martin
Marian L Neuhouser
Mara Z Vitolins
Yiqing Song
Stephen Kritchevsky
JoAnn E Manson
Fred Hutch Cancer Center · USHarvard University · USWake Forest University · USGeorge Washington University · USKaiser Permanente Center for Health Research · USReading Hospital · USThe Ohio State University · USUniversity of Alabama at Birmingham · USUniversity of Iowa · USUniversity of Tennessee Health Science Center · US

Funding

Biochemical Heterogeneity in Morbidly Obese Women in the WHI Observational StudyR01HL083326 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MACKEY, RACHEL HART · 2006 to 2008
$870k
NHLBI NIH HHS HHSN268201100001INHLBI NIH HHS HHSN268201100002INHLBI NIH HHS HHSN268201100003INHLBI NIH HHS HHSN268201100004INHLBI NIH HHS HHSN268201100046CNHLBI NIH HHS R01 HL083326NIA NIH HHS HHSN271201100004CWHI NIH HHS HHSN268201100001CWHI NIH HHS HHSN268201100002CWHI NIH HHS HHSN268201100003CWHI NIH HHS HHSN268201100004C
6 · The paper itself

Abstract

objectiveThe objective of this study was to evaluate whether increased serum 25-hydroxyvitamin D3 (25OHD3) concentrations, in response to calcium/vitamin D (CaD) supplementation, are associated with improved lipids in postmenopausal women.

methodsThe parent trial was a double-blind, randomized, placebo-controlled, parallel-group trial designed to test the effects of CaD supplementation (1,000 mg of elemental calcium + 400 IU of vitamin D3 daily) versus placebo in postmenopausal women. Women from the general community, including multiple sites in the United States, were enrolled between 1993 and 1998. This cohort included 300 white, 200 African-American, and 100 Hispanic participants who were randomly selected from the Women's Health Initiative CaD trial. Serum 25OHD3 and lipid (fasting plasma triglycerides [TG], high-density lipoprotein cholesterol [HDL-C], and calculated low-density lipoprotein cholesterol [LDL-C]) levels were assessed before and after CaD randomization.

resultsThere was a 38% increase in mean serum 25OHD3 concentrations after 2 years (95% CI, 1.29-1.47, P < 0.001) for women randomized to CaD (24.3 ng/mL postrandomization mean) compared with placebo (18.2 ng/mL). Women randomized to CaD had a 4.46-mg/dL mean decrease in LDL-C (P = 0.03). Higher concentrations of 25OHD3 were associated with higher HDL-C levels (P = 0.003), along with lower LDL-C and TG levels (P = 0.02 and P < 0.001, respectively).

conclusionsSupplemental CaD significantly increases 25OHD3 concentrations and decreases LDL-C. Women with higher 25OHD3 concentrations have more favorable lipid profiles, including increased HDL-C, lower LDL-C, and lower TG. These results support the hypothesis that higher concentrations of 25OHD3, in response to CaD supplementation, are associated with improved LDL-C.

Indexed as

Dietary SupplementsPostmenopauseCalcifediolCalcium, DietaryCholesterolCholesterol, HDLCholesterol, LDLDouble-Blind MethodFemaleHumansHyperlipidemiasMiddle AgedTreatment OutcomeVitamin DWomen's HealthCalcifediolCalcium, DietaryCholesterolCholesterol, HDLCholesterol, LDLVitamin D

Identifiers

PMID24594863
PMCPMC5234488
OpenAlexW1973294802

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.